PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2010 | 61 |
Tytuł artykułu

An assessment of fats of plant and animal origin in relation to their atherogenic and thrombogenic indices

Treść / Zawartość
Warianty tytułu
PL
Ocena tłuszczów pochodzenia roślinnego i zwierzęcego pod kątem ich indeksów aterogennego i trombogennego
Języki publikacji
EN
Abstrakty
EN
PL
Słowa kluczowe
Wydawca
-
Rocznik
Tom
61
Opis fizyczny
p.107-114,ref.
Twórcy
autor
  • Institute of Animal Breeding, Wroclaw University of Environmental and Life Sciences, Wroclaw, Poland
Bibliografia
  • Balk E.M., Lichtenstein A.H., Chung M., Kupelnick B., Chew P., Lau J., 2006. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: A systematic review. Atheroscle¬rosis, 189 (1): 19-30.
  • Bodkowski R., Sokoła E., Patkowska-Sokoła B., Usysdus Z., Zawadzki W., Janczak M., 2009. Enrichment of fish oil in bioactive fatty acids EPA and DHA and its application in order to decrease lipid indices of blood. New concept in food evaluation - Neutraceticals-Analyses- -Consumer. Eds. T. Trziszka, M. Oziembłowski, Monography LXXIV Uniwersytet Przyrod¬niczy Wrocław. Chepter 1. Food Improvement, Nutraceuticals and Organic Food: 50-58.
  • Castro I.A., Monteiro V.C.B., Barroso L.P., Bertolami M.C., 2007. Effect of eicosapentaenoic/do- cosahexaenoic fatty acids and soluble fibers on blood lipids of individuals classified into diffe¬rent levels of lipidemia. Nutrition, 23 (2): 127-137.
  • Chang C., Seo T., Matzsuzaki M., Worgall T.S., Deckelbaum R.J., 2009. N-3 fatty acids reduce arterial LDL cholesterol delivery and arterial lipoprotein lipase levels and lipase distribution. Artherriosclerosis Thromb. Vasc. Biol., 29 (4): 555-561.
  • Cromwell W.C., James D., 2004. Low density lipoprotein particle number and risk for cardiovascu¬lar disease. Current Atherosclerosis Reports, 6: 381-387.
  • Cundiff D.K., Lanou A.J., Nigg C.R., 2007. Relation of omega-3 fatty acid intake to other dietary- factors known to reduce coronary heart disease risk. American Journal of Cardiology, 99 (9): 1230-1233.
  • Davidson M.H., 2006. Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids. The American Journal of Cardiology, 98 (4): 27-33.
  • De Lorenzo A., Petroni M.L., De Luca P.P., Andreoli A., Morini P., Iacopino L., 2001. Use of quality control indices in moderately hypocaloric Mediterranean diet for treatment of obesity. Diabetes, Nutrition and Metabolism, 14: 181-188.
  • Fehily A.M., Pickering J.E., Yarnell J.W., Elwood D.P., 1994. Dietary indices of atherogenicity and thrombogenicity and ischaemic heart disease risk: the Caerphilly Prospective Study. British Journal of Nutrition, 71: 249-251.
  • Fernandez M.L., Avalos C., Jimenez M., 1998. Differences in response between 18 carbon fatty acids and carbon saturated fatty acids on plasma cholesterol in guinea pigs. Nutritional Re¬search, 18: 1261-1272.
  • Halpern M.J., 1995. Lipids and atherosclerosis. Molecular Aspects of Medicine, 6: 509-710.
  • Harris W.S., Miller M., Tighe A.P., Davidson M.H., Schaefer E.J., 2008. Omega-3 fatty acids and coronary heart disease risk: Clinical and mechanistic perspectives. Atherosclerosis, 197 (1): 12-24.
  • Hegsted P., Ansman L., Johnson J., Dallal G., 1993. Dietary fat and serum lipids on evaluation of the experimental data. Am. J. Clin. Nutr., 57: 875-883.
  • Henderson S., Lampel J., Hollenbeck C.B., 2008. The effects of a 4:1 eicosapentaenoic acid / doco- sahexaenoic acid fish oil supplement on plasma lipid profile. Journal of the American Dietetic Association, 108 (9): 104-115.
  • Hu F.B., 2001. The balance between ro-6 and ro-3 fatty acids and the risk of coronary heart disease. Nutrition, 17 (9): 741-742.
  • Jacobson T.A., 2006. Secondary prevention of coronary artery disease with omega-3 fatty acids. American Journal of Cardiology, 98 (4): 61-70.
  • Jequier E., George M.D., Bray M.D., 2002. Low-fat diet are preferred. American Journal Medicine, 1134: 41-46.
  • Kris-Etherton P.M., Harris W.S., Appel L.J., 2002. For the Nutrition Committee. AHA Scientific Statement. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease Circula¬tion, 106: 2747-2757.
  • Lairon D., 1997. Dietetary fatty acids and artheriosclerosis. Biomedicine & Pharmacotheraphy, 51: 333-336.
  • Librelotto J., Bastida S., Serrano A., Cofrades S., Jimenez-Colmenero F., Sanchez-Muniz F.J., 2008. Changes in fatty acids and polar material of restructured low-fat or walnut-added steaks pan-fried in olive oil. Meat Science, 80: 431-441.
  • Michalik A., Sznajderman M., 1986. Lipidy i lipoproteiny osocza. Wyd. II, PZWL, Warszawa.
  • Natarajan S., Glick H., Crigui M., Horowitz D., Lipsitz S.R., Kinosian B., 2003. Cholesterol mea¬sures to identify and treat individuals at risk for coronary heart disease. American Journal of Prevenic Medicine, 25: 50-57.
  • Patkowska-Sokoła B., Bodkowski R., Zawadzki W., Dobrzański Z., Usydus Z., Janczak M., 2008. An influence of lard application in rats feeding on lipid indices of their blood and adipose. Chemistry for Agriculture, 9: 469-475.
  • Psota T.L., Gebauer S.K., Kris-Etherton P., 2006. Dietary omega-3 fatty acid intake and cardiovas¬cular risk. American Journal of Cardiology, 98 (4), 3-18.
  • Robinson J.G., Stone N.J., 2006. Antiatherosclerotic and antithrombotic effects of omega-3 fatty acids. The American Journal of Cardiology, 98 (4): 39-49.
  • Rywik S., 1995. Przesłanki epidemiologiczne kardiologicznych programów prewencyjnych w Polsce. Profil ryzyka społeczeństwa polskiego, [w:] Hiperlipidemia a choroby układu krążenia. Red W.B. Szostak. Zakład Żywienia Klinicznego Instytutu Żywności i Żywienia, Towarzystwo Internistów Polskich, Sekcja Żywienia i Przemiany Materii, Warszawa.
  • Schmidt E.B., Rasmussen L.H., Rasmussen J.G., Joensen A.M., 2006. Fish, marine n-3 polyun¬saturated fatty vacids and coronary heart disease: A minireview with focus on clinical trial data. Prostaglandins, Leukotrienes & Essential Fatty Acids, 75 (3): 191-195.
  • Siguel E., Lerman R., 1993. Trends - fatty acid in patients with angiographically documentated coronary arterie disease. Am. J. Cardiol., 71 (11): 916-920.
  • Silva J.M., Souza J., Silva R., Tavares P., Teixeira F., 1996. The triagliceride lowering effect of fish oils is affected by fish consumption. International Journal of Cardiology, 57: 75-80.
  • Szostak W.B., Cybulska B., Naruszewicz M., 1983. Nowsze poglądy na temat miażdżycowego działania lipoprotein. Żyw. Człow. i Met., 10: 3-10.
  • Szostak W.B., Cybulska B., 1985. Metaboliczne choroby cywilizacyjne. Centrum Medyczne Kształcenia Podyplomowego, Warszawa.
  • Von Schacky C., Harris W.S., 2007. Cardiovascular benefits of omega-3 fatty acids. Cardiovascular Research, 2007, 73 (2), 310-315.
  • Weintraub W., 2002. Is atherosclerotic vascular disease related to a high-fat diet? Journal of Clinical Epidemiology, 55 (11): 1064-1072.
  • Wergedahl H., Gudbrandsen O.A., R0st T.H., Berge R.K., 2009. Combination of fish oil and fish protein hydrolysate reduces the plasma cholesterol level with a concurrent increase in hepatic cholesterol level in high-fat-fed Wistar rats. Nutrition, 2009, 25 (1): 98-104.
  • Yokoyama M., Origasa H., Matsuzaki M., Matsuzawa Y., Saito Y., 2007. Eicosapentaenoic acid for prevention of major coronary events. Lancet, 370: 215-216.
  • Yuan Y., Kitts D.D., Godin D.V., 1998. Influence of increase saturated fatty acid intake from beef tallow on antioxidant status and plasma lipids in atherosclerosis susceptible Japanese guail. Nutrition Research, 19: 461-481.
  • Zatsick N.M., Mayket P., 2007. Fish oil: Getting to the heart of it. Journal for Nurse Practitioners, 3 (2): 104-109.
  • Ziemiański Ś., Budzyńska-Topolowska J., 1991. Tłuszcze pożywienia i lipidy ustrojowe. Wyd. Nauk. PWN, Warszawa.
Typ dokumentu
Bibliografia
Identyfikatory
Identyfikator YADDA
bwmeta1.element.agro-06124c71-3a2c-47e9-8979-b5dac4608014
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.